🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › Nebraska › Omaha

Qorannoo klinikaalii Kansarii Ovarii Omaha, NE keessatti

Qorannoo 14 Kansarii Ovarii f Omaha fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nebraska Cancer Specialists, Omaha
  • XCancer, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07189871

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • University Of Nebraska Medical Center /ID# 281020, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07278336

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06799065

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Namoota walitti qabaa jiraSadarkaa 3
  • Nebraska Methodist Hospital ( Site 0004), Omaha
  • University Of Nebraska Medical Center ( Site 0035), Omaha
Umuriin 18 fi ol · Dubartoota · Haaromfame 17-Ful-2026 · NCT07318558

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nebraska Cancer Specialists, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07109726

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Namoota walitti qabaa jiraSadarkaa 2
  • Nebraska Methodist Hospital, Omaha
Umuriin 18 hanga 99 · Dubartoota · Haaromfame 15-Ful-2026 · NCT07023627

Study of NTB-928 in R/R OC

Namoota walitti qabaa jiraSadarkaa 1
  • University of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Dubartoota · Haaromfame 20-Hag-2026 · NCT07690189

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Namoota walitti qabaa jira
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Nebraska Medicine-Village Pointe, Omaha
  • fi 4 dabalataa
Umuriin 35 hanga 50 · Dubartoota · Haaromfame 07-Hag-2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Nebraska Medicine-Village Pointe, Omaha
  • fi 8 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06580314

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Namoota walitti qabaa jiraSadarkaa 2
  • Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nebraska Cancer Specialists, Omaha
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06710756

Integrated Cancer Repository for Cancer Research

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Methodist Estabrook Cancer Center, Omaha
  • Nebraska Methodist Health System, Omaha
  • University of Nebraska Medical Center, Omaha
  • fi 1 dabalataa
Umuriin 19 hanga 110 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT02012699

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Omaha
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo Omaha keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.